The Foundation of Sarcoidosis Research (FSR) maintains a strong Scientific Advisory Board (SAB) composed of world renowned key opinion leaders within the fields of sarcoidosis, medical research, therapy development, and medical practice. The SAB helps advance FSR towards its mission dedicated to finding a cure for this disease and to improving care for sarcoidosis patients.

Elliott Crouser, MD

SAB Chair

Ohio State University

 

Robert Baughman, MD

University of Cincinnati

 

John Belperio, MD

UCLA Medical Center

 

Edward Chen, MD

Johns Hopkins University

 

Ulrich Costabel, MD, FERS

University of Duisburg-Essen

 

Seamas Donnelly, MD

Trinity College Dublin

 

Wonder Drake, MD

Vanderbilt University

 

Marjolein Drent, MD, PhD

St. Antonius Hospital

 

Andrew Fontenot, MD

University of Colorado

 

Skip Garcia, MD

University of Arizona

Ennis James, MD

Medical University of South Carolina

 

Craig Lipset

Managing Partner

Clinical Innovation Partners

 

Lisa Maier, MD

National Jewish Health

 

Adam Morgenthau, MD

Icahn School of Medicine at Mount Sinai

 

Ogugua Obi

East Carolina University

 

Misha Rosenbach, MD

University of Pennsylvania

 

Milton Rossman, MD

University of Pennsylvania

 

Barney Stern, MD

University of Maryland

 

Dominique Valeyre, MD

Hôpital Avicenne

Please note: While FSR receives guidance and input from our Scientific Advisory Board (SAB), it is not to be implied that all SAB members support or are in agreement in each specific FSR initiative or approach. As with most professional groups, members may have differing perspectives and opinions on various issues. FSR’s intent is always to work toward consensus with our experts as much as feasible while addressing patient and research needs.

 

Meet our staff.